JPS6367657B2 - - Google Patents

Info

Publication number
JPS6367657B2
JPS6367657B2 JP56043586A JP4358681A JPS6367657B2 JP S6367657 B2 JPS6367657 B2 JP S6367657B2 JP 56043586 A JP56043586 A JP 56043586A JP 4358681 A JP4358681 A JP 4358681A JP S6367657 B2 JPS6367657 B2 JP S6367657B2
Authority
JP
Japan
Prior art keywords
serum
plasma
fine particles
weight
partition wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56043586A
Other languages
Japanese (ja)
Other versions
JPS57159561A (en
Inventor
Seiichiro Honda
Hiroshi Ogawara
Yasumasa Kashima
Mutsumi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP4358681A priority Critical patent/JPS57159561A/en
Publication of JPS57159561A publication Critical patent/JPS57159561A/en
Publication of JPS6367657B2 publication Critical patent/JPS6367657B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Centrifugal Separators (AREA)

Description

【発明の詳細な説明】 本発明は、試料血液を遠心分離操作により血清
または血漿と血球とに分離する際に使用される分
離剤に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a separation agent used when a blood sample is separated into serum or plasma and blood cells by centrifugation.

近年、臨床検査部門における血液成分の検査
が、極めて重要視され、検査件数は増加の一途を
たどつている。その中で、血清学的検査等におい
ては、試料として血清または血漿のみを用いる項
目が多く、検査のための前処理として、血清また
は血漿と血球とを分離する事が必要である。この
ため、従来は遠心分離操作のみにより、血球部分
を沈殿せしめた後、ピペツトにて吸い上げる方法
で血清または血漿を採取していた。しかし乍ら、
この方法は分離が不十分である上に大変手間がか
かる。最近になつて、この血清または血漿の採取
を簡便かつ高収率で行えるよう種々の方法が工夫
されるようになつた。
In recent years, testing of blood components in clinical laboratory departments has become extremely important, and the number of tests performed has continued to increase. Among these, many serological tests use only serum or plasma as a sample, and it is necessary to separate serum or plasma from blood cells as pretreatment for the test. For this reason, conventionally, serum or plasma has been collected only by centrifugation to precipitate the blood cell portion and then sucking it up with a pipette. However,
This method provides insufficient separation and is very time consuming. Recently, various methods have been devised to allow serum or plasma to be collected easily and with high yield.

その一つに試料血液中に血清または血漿との中
間の比重を有する物質を加え、遠心分離操作によ
つて、該物質を両者の中間に位置させて、隔壁を
形成せしめる方法がある。この方法によれば、デ
カンテーシヨンのみにより血清または血漿を分取
する事が可能であり、時間及び労力の削減を図り
うるが、次の様な難点も有していた。即ち、上記
隔壁形成用材料の形態としては、現在までに固体
形態、液体形態及びこれらの混合物の3種類のも
のが提案されており、固体形態のものとしては、
例えばポリスチレンの粉末状材料あるいはペレツ
ト状材料等があるが、これらを用いた場合には、
隔壁としての機能が不十分であるため、血球の血
清又は血漿中への混入が起つたり、隔壁自体が破
壊され易いなどの種々の欠点があつた。
One method is to add a substance having a specific gravity intermediate to that of serum or plasma to a blood sample, and use centrifugation to position the substance between the two to form a partition wall. According to this method, it is possible to separate serum or plasma only by decantation, and it is possible to reduce time and labor, but it also has the following drawbacks. That is, three types of forms of the above-mentioned partition wall forming material have been proposed so far: solid form, liquid form, and mixtures thereof.
For example, there are polystyrene powder materials or pellet materials, but when these are used,
Since the function as a septum is insufficient, there have been various drawbacks such as contamination of blood cells into serum or plasma and a tendency for the septum itself to be destroyed.

又、液体形態のものとしては液状のアクリル重
合体等が、固体と液体の混合物としてはシリコー
ンにシリカ粉末を加えたものがあるが、これらは
スピツツ管の壁面に強く粘着するため、使用後ス
ピツツ管を洗浄して再使用するに際して洗浄に時
間を要し面倒であり、再使用時の測定値になんら
かの影響を与え、臨床検査において誤つた判定を
与える原因を有するという欠点があつた。
In addition, liquid forms such as liquid acrylic polymers, and solid/liquid mixtures include silicone and silica powder, but these stick strongly to the walls of spitz tubes, so they cannot be removed from the spitz tube after use. When the tube is cleaned and reused, cleaning is time-consuming and troublesome, and it has the disadvantage that it has some influence on the measured values upon reuse, causing erroneous judgments in clinical tests.

本発明は上述の欠点を解消するため鋭意研究し
た結果なされたものであり、形成される隔壁の強
度がすぐれ、又、この隔壁を使用後速やかに除去
してスピツツ管を洗浄することができ、しかも極
めて簡便に且つ精度よく血清又は血漿を血液から
分離できる新規な血清又は血漿分離剤を提供する
ことを目的とする。
The present invention was made as a result of intensive research to eliminate the above-mentioned drawbacks, and the formed partition wall has excellent strength, and the partition wall can be quickly removed after use to clean the Spitz tube. Moreover, it is an object of the present invention to provide a novel serum or plasma separating agent that can separate serum or plasma from blood extremely simply and accurately.

本発明の要旨は25℃における比重が1.03〜
1.08、粒径が0.1〜5mmにして、25℃でのボール
タツク値が3〜7であり、アクリル酸エステルも
しくはメタクリル酸エステルのモノマーの単独又
はこれらと共重合し得るモノマーを重合して得ら
れる、感圧粘着性を有する微粒子よりなることを
特徴とする血清又は血漿分離剤に存する。
The gist of the present invention is that the specific gravity at 25℃ is 1.03 ~
1.08, the particle size is 0.1 to 5 mm, the ball tack value at 25°C is 3 to 7, and is obtained by polymerizing an acrylic ester or methacrylic ester monomer alone or a monomer that can be copolymerized with these. The present invention relates to a serum or plasma separating agent characterized by comprising fine particles having pressure-sensitive adhesive properties.

本発明における感圧粘着性を有する微粒子と
は、加圧されると相互に粘着接合する性質を有す
る微粒子を指し、アクリル系の感圧粘着性微粒子
が用いられる。これら粘着性を有する微粒子の粒
径としては0.1〜5mmのものが用いられ、又粒径
がそろつているほど好ましい。又形状は、特に限
定されないが、球状のものが好ましい。上記、粘
着性を有する微粒子の比重は1.03〜1.08の範囲に
定められるのであり、これは、上記微粒子の比重
が1.03未満であると、当該粘着性を有する微粒子
が血清又は血漿の相中に浮遊し、又1.08を越える
と、当該粘着性を有する微粒子が血球の相中に沈
滞してしまつて、二層間における隔壁が形成でき
なくなるという理由に基づく。尚、上記微粒子の
比重調整のため、これら粘着性を有する微粒子中
にシリカ等の無機物を添加しても良い。
The fine particles having pressure-sensitive adhesive properties in the present invention refer to fine particles having the property of adhesively bonding to each other when pressurized, and acrylic pressure-sensitive adhesive fine particles are used. The particle size of these sticky fine particles is preferably 0.1 to 5 mm, and it is preferable that the particle sizes are uniform. Further, the shape is not particularly limited, but a spherical shape is preferable. The specific gravity of the above-mentioned sticky particles is set in the range of 1.03 to 1.08. This means that if the specific gravity of the above-mentioned particles is less than 1.03, the sticky particles will float in the serum or plasma phase. However, if it exceeds 1.08, the adhesive particles will settle in the blood cell phase, making it impossible to form a partition wall between the two layers. Incidentally, in order to adjust the specific gravity of the fine particles, an inorganic substance such as silica may be added to these sticky fine particles.

本発明における微粒子の有する粘着性の指標
は、粘着剤の分野で慣用のJ.Dowの方法による粘
着力を表わすボールタツク値が採用される。即
ち、測定しようとする粘着性を有する微粒子をエ
タノール等の有機溶剤に分散せしめ、ポリエステ
ル等のフイルム基体上に塗布し、乾燥させた後、
これを30度の傾斜を有する台の上に固定する。次
いで台の上部より各種大きさのステンレス球を該
球の大きい順からころがし、長さ10cmの粘着剤を
塗布した領域で停止しうるステンレス球の大きさ
でもつてボールタツク値を表わす。例えばX/32
インチ径のステンレス球を用いて上記条件を満し
た場合、ボールタツク値はXである。
As an index of the adhesiveness of the fine particles in the present invention, a ball tack value representing adhesive strength is used according to the method of J. Dow, which is commonly used in the field of adhesives. That is, fine particles having the tackiness to be measured are dispersed in an organic solvent such as ethanol, coated on a film substrate such as polyester, and dried.
This is fixed on a table with a slope of 30 degrees. Next, stainless steel balls of various sizes are rolled from the top of the table, starting from the largest ball, and the ball tack value is expressed as the size of the stainless steel ball that can stop in the adhesive-applied area with a length of 10 cm. For example, X/32
When the above conditions are satisfied using inch diameter stainless steel balls, the ball tack value is X.

本発明における粘着性を有する微粒子は上記測
定方法による25℃でのボールタツク値が3〜7の
ものが用いられる。
The adhesive fine particles used in the present invention have a ball tack value of 3 to 7 at 25 DEG C. as measured by the above-mentioned measuring method.

本発明における粘着性を有する微粒子を製造す
る方法としては、例えば2―エチルヘキシルアク
リレート、ブチルアクリレート等のアクリル酸エ
ステルモノマーの単独若しくはこれと共重合し得
るモノマーと混合して、油溶性の触媒の存在下
で、水中にて懸濁重合すれば、アクリル系の粘着
性を有する微粒子が得られる。又、上記重合の
際、安定剤としては、ポリビニルアルコールやポ
リアクリル酸の様な水溶性ポリマー、適当な界面
活性剤等、油溶性の触媒としては、ベンゾイルパ
ーオキサイド、メチルエチルケトンパーオキサイ
ド等の過酸化物やアゾビスイソブチロニトリル等
が用いられる。
In the present invention, the adhesive fine particles can be produced by mixing an acrylic acid ester monomer such as 2-ethylhexyl acrylate or butyl acrylate alone or with a monomer that can be copolymerized therewith in the presence of an oil-soluble catalyst. If suspension polymerization is carried out in water below, fine particles having acrylic adhesive properties will be obtained. In addition, during the above polymerization, stabilizers include water-soluble polymers such as polyvinyl alcohol and polyacrylic acid, suitable surfactants, etc., and oil-soluble catalysts include peroxides such as benzoyl peroxide and methyl ethyl ketone peroxide. or azobisisobutyronitrile, etc. are used.

上記モノマーとしては、特に炭素数が4〜10の
第1級若しくは第2級アルコールのアクリル酸エ
ステル若しくはメタクリル酸エステルを用いるの
が好ましい。又、これらのモノマーと共重合可能
なスチレン、メチルメタクリレート、アクリルア
ミド、アクリロニトリル等のモノマーを併用して
も良く、特に、ジビニルベンゼンやポリエチレン
グリコールジアクリレートの様な多官能性モノマ
ーを併用すれば、広い温度範囲に渡つて適度な微
粘着性を保持できる微粒子が得られる。この様に
して合成された粘着性を有する微粒子はよく水洗
して安定剤等の残留不純物を完全に除去した後、
乾燥して用いることが重要である。
As the above-mentioned monomer, it is particularly preferable to use an acrylic ester or methacrylic ester of a primary or secondary alcohol having 4 to 10 carbon atoms. In addition, monomers that can be copolymerized with these monomers such as styrene, methyl methacrylate, acrylamide, acrylonitrile, etc. may be used in combination, and in particular, if polyfunctional monomers such as divinylbenzene and polyethylene glycol diacrylate are used in combination, a wide range of possibilities can be obtained. Fine particles can be obtained that can maintain a moderate degree of tackiness over a temperature range. After the adhesive fine particles synthesized in this way are thoroughly washed with water to completely remove residual impurities such as stabilizers,
It is important to use it dry.

本発明分離剤を用いて血清又は血漿と血球とを
分離するには、試料血液に該分離剤を添加して遠
心分離操作を行えばよく、その結果、上部血清又
は血漿層と下部血球層との中間に本発明分離剤に
よる隔壁が形成されるので、デカンテーシヨン等
により血清又は血漿を簡単に精度よく採取するこ
とができる。
In order to separate serum or plasma from blood cells using the separation agent of the present invention, it is sufficient to add the separation agent to sample blood and perform a centrifugation operation. As a result, an upper serum or plasma layer and a lower blood cell layer are separated. Since a partition wall is formed by the separation agent of the present invention in the middle of the membrane, serum or plasma can be easily and accurately collected by decantation or the like.

本発明の血清又は血漿分離剤は、25℃における
比重が1.03〜1.08で且つ感圧粘着性を有する微粒
子であるので、特別に強力な遠心力を必要とせず
通常の遠心分離条件にて容易に血清又は血漿層と
血球層との間に隔壁が形成され、該隔壁は遠心分
離時の圧力により粘着性を有する微粒子同志が互
いに接合することにより形成されているので、該
隔壁を破壊することなくデカンテーシヨン等にて
分離した血清又は血漿を容易に精度よく採取する
ことができる。又、血清又は血漿を採取後、スピ
ツツ管内壁に残存することなく上記の隔壁をスパ
チユラ、ガラス棒等で簡単に除去することができ
るのでスピツツ管を洗浄して再使用することがで
きる。
The serum or plasma separating agent of the present invention is a fine particle with a specific gravity of 1.03 to 1.08 at 25°C and has pressure-sensitive adhesive properties, so it can be easily separated under normal centrifugation conditions without the need for a particularly strong centrifugal force. A partition wall is formed between the serum or plasma layer and the blood cell layer, and the partition wall is formed by adhesive particles bonding to each other due to the pressure during centrifugation, so the partition wall is not destroyed. Serum or plasma separated by decantation or the like can be easily and accurately collected. Furthermore, after serum or plasma is collected, the septum can be easily removed with a spatula, a glass rod, etc. without remaining on the inner wall of the Spittz tube, so the Spitz tube can be cleaned and reused.

以下、本発明を実施例により説明する。 Hereinafter, the present invention will be explained by examples.

実施例 1 イオン交換水200重量部、ポリビニルアルコー
ル(重合度1500)0.5重量部、ブチルアクリレー
ト80重量部、スチレン15重量部、ジビニルベンゼ
ン5重量部及び過酸化ベンゾイル0.3重量部、を
反応容器に投入し、窒素気流中にて80℃で10時間
反応させて、粘着性を有する微粒子の水分散液を
調整した。この分散液より微粒子を分離してイオ
ン交換水で数回水洗してポリビニルアルコールを
除去した後、−50℃で凍結乾燥を行い粘着性を有
する微粒子を得た。この微粒子の粒径は0.1〜0.5
mmであり、ボールタツク値は4であつた。この粘
着性を有する微粒子約2gをポリスチレン製スピ
ツツ管の底に入れ、次いで採血した血液8mlを加
えて3000rpmで5分間遠心分離したところ、上記
微粒子は互いに接合して、上部血清層と下部血球
層の中間で隔壁を形成した。この隔壁はデカンテ
ーシヨンによつて破壊することなく、スピツツ管
より血清を容易に採取することができた。又、血
清採取後上記隔壁をスパチユラでスピツツ管壁に
残存することなく容易に除去することができた。
Example 1 200 parts by weight of ion-exchanged water, 0.5 parts by weight of polyvinyl alcohol (degree of polymerization 1500), 80 parts by weight of butyl acrylate, 15 parts by weight of styrene, 5 parts by weight of divinylbenzene, and 0.3 parts by weight of benzoyl peroxide were charged into a reaction vessel. The mixture was reacted at 80° C. for 10 hours in a nitrogen stream to prepare an aqueous dispersion of sticky fine particles. Fine particles were separated from this dispersion, washed several times with ion-exchanged water to remove polyvinyl alcohol, and then freeze-dried at -50°C to obtain sticky fine particles. The particle size of this fine particle is 0.1~0.5
mm, and the ball tack value was 4. Approximately 2 g of these sticky particles were placed in the bottom of a polystyrene Spitz tube, and then 8 ml of collected blood was added and centrifuged at 3000 rpm for 5 minutes. The particles bonded to each other, forming an upper serum layer and a lower blood cell layer. A partition wall was formed in the middle. This septum was not destroyed by decantation, and serum could be easily collected from the Spitz tube. Furthermore, after serum collection, the septum could be easily removed with a spatula without remaining on the wall of the Spitz canal.

実施例 2 イオン交換水200重量部、ポリビニルアルコー
ル(重合度1500)0.5重量部、2―エチルヘキシ
ルアクリレート70重量部、メチルメタクリレート
20重量部、エチレングリコールジメチルメタクリ
レート10重量部及び過酸化ベンゾイル0.3重量部
を反応容器に投入し、実施例1と同様に反応させ
た後、分離・水洗し、−50℃で凍結乾燥させた粒
径1〜2mmの粘着性を有する微粒子を得た。この
微粒子のボールタツク値は4であつた。この粘着
性を有する微粒子約2gをガラス製スピツツ管の
底に入れ、次いで採血した血液5mlを加えて、
3000rpmで5分間遠心分離したところ、上記微粒
子は互いに接合して上部血清層と下部血球層の中
間で隔壁を形成した。この隔壁はデカンテーシヨ
ンによつて破壊することなく、スピツツ管より血
清を容易に採取することができた。又、血清採取
後上記隔壁をスパチユラでスピツツ管壁に残存す
ることなく容易に除去することができた。
Example 2 200 parts by weight of ion-exchanged water, 0.5 parts by weight of polyvinyl alcohol (degree of polymerization 1500), 70 parts by weight of 2-ethylhexyl acrylate, methyl methacrylate
20 parts by weight, 10 parts by weight of ethylene glycol dimethyl methacrylate, and 0.3 parts by weight of benzoyl peroxide were charged into a reaction vessel and reacted in the same manner as in Example 1, then separated, washed with water, and freeze-dried at -50°C. Adhesive fine particles having a diameter of 1 to 2 mm were obtained. The ball tack value of this fine particle was 4. Approximately 2 g of these sticky particles were placed at the bottom of a glass Spitz tube, and then 5 ml of the collected blood was added.
When centrifuged at 3000 rpm for 5 minutes, the microparticles bonded to each other to form a partition wall between the upper serum layer and the lower blood cell layer. This septum was not destroyed by decantation, and serum could be easily collected from the Spitz tube. Furthermore, after serum collection, the septum could be easily removed with a spatula without remaining on the wall of the Spitz canal.

Claims (1)

【特許請求の範囲】[Claims] 1 25℃における比重が1.03〜1.08、粒径が0.1〜
5mmにして、25℃でのボールタツク値が3〜7で
あり、アクリル酸エステルもしくはメタクリル酸
エステルのモノマーの単独又はこれらと共重合し
得るモノマーを重合して得られる、感圧粘着性を
有する微粒子よりなることを特徴とする血清又は
血漿分離剤。
1 Specific gravity at 25°C is 1.03 to 1.08, particle size is 0.1 to
5 mm, has a ball tack value of 3 to 7 at 25°C, and has pressure-sensitive adhesive properties obtained by polymerizing an acrylic ester or methacrylic ester monomer alone or a monomer that can be copolymerized with these monomers. A serum or plasma separating agent characterized by comprising:
JP4358681A 1981-03-24 1981-03-24 Serum or blood plasma-separator Granted JPS57159561A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4358681A JPS57159561A (en) 1981-03-24 1981-03-24 Serum or blood plasma-separator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4358681A JPS57159561A (en) 1981-03-24 1981-03-24 Serum or blood plasma-separator

Publications (2)

Publication Number Publication Date
JPS57159561A JPS57159561A (en) 1982-10-01
JPS6367657B2 true JPS6367657B2 (en) 1988-12-27

Family

ID=12667879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4358681A Granted JPS57159561A (en) 1981-03-24 1981-03-24 Serum or blood plasma-separator

Country Status (1)

Country Link
JP (1) JPS57159561A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7110360B2 (en) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー Freeze-drying method
CN113614477B (en) 2019-03-14 2023-04-28 泰尔茂比司特生物技术有限公司 Freeze-drying loading tray assembly and system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52137181A (en) * 1976-05-10 1977-11-16 Terumo Corp Tube for collecting blood to separate serum or blooddplasma
JPS5328494A (en) * 1976-08-27 1978-03-16 Ajinomoto Kk Separation of serum and blood clot
JPS5751331Y2 (en) * 1977-10-03 1982-11-09
JPS55132957A (en) * 1979-04-04 1980-10-16 Ono Pharmaceut Co Ltd Blood coagulation accelerating vessel

Also Published As

Publication number Publication date
JPS57159561A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
US4839416A (en) Low tack microsphere adhesive
KR20000016243A (en) Composite pressure sensitive adhesive microsphere
JPH03111473A (en) Pressure sensitive adhesive agent comprising hollow adhesive microspherical body and macromonomer containing binder copolymer
KR20020075361A (en) Pressure sensitive adhesives possessing high load bearing capability
JPS587187B2 (en) Serum or plasma separation
JP5173406B2 (en) Method for producing composite absorbent material for chromatographic separation of biopolymers
USH509H (en) Preparation of adhesives
US4559303A (en) Carrier composed of particulate polymer
JPS6367657B2 (en)
JPWO2017204187A1 (en) Extracellular vesicle collection method and extracellular vesicle container
JPH052015A (en) Blood separating agent
JP2530722B2 (en) Sealant for serum separation and blood separation method
JPS6367659B2 (en)
JP2005083904A (en) Magnetic particles
JP4684434B2 (en) Virus concentration particle, virus concentration reagent, virus concentration method and virus detection method
JP2005083905A (en) Magnetic particles
JP2745418B2 (en) Method for producing porous polymer particles
JP2007170907A (en) Filler graft-polymerized with alkoxyalkyl acrylate
JP2003277455A (en) Method for producing polymer particles, polymer particles and physiologically active substance carrier
JP2949379B2 (en) Serum separation sealant
JPS6116023B2 (en)
JP4310854B2 (en) Carrier particles for diagnostic agents and diagnostic agents
US20250331750A1 (en) Separating gel for blood collection tubes
JPS636046B2 (en)
JPH05320359A (en) Method for removing fine particle attached to surface of porous crosslinked copolymer particle